Antiviral besifovir may be a safer alternative for long-term hepatitis B treatment
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
pharmaphorum1d
Hepatitis drug wins award for cure rate and efficacy
Hepatitis C drug Ganovo won a top clinical ... Non-cirrhotic patients on a treatment regimen of Ganovo, which is produced by Chinese biotech company, Ascletis, demonstrated a cure rate of 97% ...
EurekAlert!6d
New study by Korea University researchers reveals a safer alternative for long-term hepatitis B treatment
Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil ...
News Medical13d
Researchers move closer to a functional cure for chronic hepatitis B
By focusing on chromatin-modifying enzymes, viral proteins, and noncoding RNAs, the researchers hope to uncover new pathways for a functional cure for chronic hepatitis B. The review highlights the ...